Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 231,718 shares at $56.95 ($13.3M) on 2024-07-30, disclosed to the SEC on 2024-07-31.
Open-market sale of $13.3M VKTX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.95 | 65,941 | $3.8M | 28.1% |
| 2 | $56.95 | 65,941 | $3.8M | 28.1% |
| 3 | $57.81 | 19,501 | $1.1M | 8.5% |
| 4 | $57.81 | 19,501 | $1.1M | 8.5% |
| 5 | $58.78 | 30,417 | $1.8M | 13.4% |
| 6 | $58.78 | 30,417 |
| $1.8M |
| 13.4% |
| Total | $57.58 avg | 231,718 | $13.3M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $2.7M | — | Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |